CUSIP: 03836N103
Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
34,222,059
-
Share change
-
-1,593,165
-
Total reported value
-
$19,089,580
-
Put/Call ratio
-
0%
-
Price per share
-
$0.56
-
Number of holders
-
37
-
Value change
-
-$3,211,938
-
Number of buys
-
8
-
Number of sells
-
30
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q3 2022
-
Previous quarter:
Q1 2022
Recent filing periods for CUSIP 03836N103:
Institutional Holders of APTINYX INC - COM (APTX) as of Q2 2022
As of 30 Jun 2022,
APTINYX INC - COM (APTX) was held by
37 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
34,222,059 shares.
The largest 10 holders included
Bain Capital Life Sciences Investors, LLC, Artal Group S.A., ADAMS STREET PARTNERS LLC, New Leaf Venture Partners, L.L.C., VANGUARD GROUP INC, Frazier Life Sciences Management, L.P., MILLENNIUM MANAGEMENT LLC, BlackRock Inc., RENAISSANCE TECHNOLOGIES LLC, and ORBIMED ADVISORS LLC.
This page lists
37
institutional shareholders reporting positions in this security
for the Q2 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.